• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Product › Details

pain drug

	Next higher product group	analgesic / antirheumatic
	Status	1998-01-01 sales existent

Record changed: 2021-03-28

Advertisement

More documents for pain drug

• [1] Grünenthal GmbH. (4/12/21). "Press Release: Grünenthal Acquires Mestex AG and Its Phase-III-ready Investigational Medicine MTX-071 for the Treatment of Pain Associated with Osteoarthritis of the Knee". Aachen....
• [2] Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde....
• [3] AlgoTherapeutix S.A.S.. (11/24/20). "Press Release: AlgoTherapeutix Raises €12M to Take ATX01 into Clinical Development in Chemotherapy-induced Peripheral Neuropathy". Paris....
• [4] Grünenthal GmbH. (9/10/19). "Press Release: Grünenthal and Mesoblast Enter Strategic Partnership for Europe and Latin America to Develop and Commercialise Innovative Cell Therapy for the Treatment of Chronic Low Back Pain". Aachen & Melbourne....
• [5] Grünenthal GmbH. (9/3/19). "Press Release: Grünenthal and UniQuest Partner to Develop Novel Drug Candidates for Chronic Neuropathic Pain". Aachen & Brisbane....
• [6] Grünenthal GmbH. (8/13/19). "Pressemitteilung: Einigung über Neuausrichtung der Forschungs- und Entwicklungsorganisation bei Grünenthal". Aachen....
• [7] Grünenthal GmbH. (5/8/19). "Press Release: Grünenthal to Strengthen Core Competencies in R&D". Aachen....
• [8] Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen....
• [9] Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel....
• [10] Iontas Ltd.. (5/30/18). "Press Release: Iontas Awarded £556K ($737K) from Innovate UK to Develop Therapies for Chronic Pain Management". Cambridge....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.